Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Non-Current Deferred Tax Liability (2016 - 2025)

Prestige Consumer Healthcare (PBH) has 15 years of Non-Current Deferred Tax Liability data on record, last reported at $449.3 million in Q4 2025.

  • For Q4 2025, Non-Current Deferred Tax Liability rose 8.72% year-over-year to $449.3 million; the TTM value through Dec 2025 reached $449.3 million, up 8.72%, while the annual FY2025 figure was $419.6 million, 3.96% up from the prior year.
  • Non-Current Deferred Tax Liability reached $449.3 million in Q4 2025 per PBH's latest filing, up from $444.9 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $484.8 million in Q1 2022 and bottomed at $384.0 million in Q2 2023.
  • Average Non-Current Deferred Tax Liability over 5 years is $429.9 million, with a median of $433.2 million recorded in 2021.
  • Peak YoY movement for Non-Current Deferred Tax Liability: rose 16.19% in 2021, then decreased 13.24% in 2023.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $444.8 million in 2021, then rose by 2.48% to $455.8 million in 2022, then fell by 12.87% to $397.1 million in 2023, then rose by 4.06% to $413.3 million in 2024, then grew by 8.72% to $449.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Deferred Tax Liability were $449.3 million in Q4 2025, $444.9 million in Q3 2025, and $426.9 million in Q2 2025.